D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Amazon
AMZN
|
$745M |
| 2 |
Apple
AAPL
|
$387M |
| 3 |
Bristol-Myers Squibb
BMY
|
$296M |
| 4 |
Keurig Dr Pepper
KDP
|
$279M |
| 5 |
Meta Platforms (Facebook)
META
|
$259M |
Top Sells
| 1 |
TWX
Time Warner Inc
TWX
|
$648M |
| 2 |
Merck
MRK
|
$465M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$404M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
$339M |
| 5 |
T-Mobile US
TMUS
|
$264M |
Sector Composition
| 1 | Technology | 17.8% |
| 2 | Consumer Discretionary | 15.64% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 11.5% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Chemed
CHE
$6.79B
| $36.9M | 0.05% |
+114,721
| New | +$36.9M |
|
352
Exelixis
EXEL
$10.2B
| $36.8M | 0.05% |
1,709,611
-44,699
| -3% | -$962K |
|
|
TWOU
353
DELISTED
2U, Inc.
TWOU
| $36.7M | 0.05% |
14,652
+6,920
| +89% | +$17.3M |
|
|
CTLT
354
DELISTED
CATALENT, INC.
CTLT
| $36.7M | 0.05% |
876,687
+800,509
| +1,051% | +$33.5M |
|
|
CJ
355
DELISTED
C&J Energy Services, Inc.
CJ
| $36.7M | 0.05% |
1,555,827
-302,149
| -16% | -$7.13M |
|
356
Service Corp International
SCI
$10.9B
| $36.1M | 0.05% |
1,008,680
+282,456
| +39% | +$10.1M |
|
357
Baxter International
BAX
$12.5B
| $35.8M | 0.05% |
484,319
-591,086
| -55% | -$43.6M |
|
358
Haemonetics
HAE
$2.62B
| $35.6M | 0.05% |
397,321
+346,415
| +680% | +$31.1M |
|
359
Equity Residential
EQR
$25.5B
| $35.6M | 0.05% |
559,308
+40,892
| +8% | +$2.6M |
|
|
WLL
360
DELISTED
Whiting Petroleum Corporation
WLL
| $35.1M | 0.05% |
8,879
+7,829
| +746% | +$31M |
|
361
Monster Beverage
MNST
$61B
| $35M | 0.05% |
1,221,714
+1,103,692
| +935% | +$31.6M |
|
362
Telus
TU
$25.3B
| $34.9M | 0.05% |
1,964,384
+300,800
| +18% | +$5.35M |
|
363
Entergy
ETR
$39.2B
| $34.9M | 0.05% |
863,726
-133,738
| -13% | -$5.4M |
|
364
Novo Nordisk
NVO
$245B
| $34.7M | 0.05% |
+1,503,382
| New | +$34.7M |
|
365
Simon Property Group
SPG
$59.5B
| $34.6M | 0.05% |
203,141
+110,720
| +120% | +$18.8M |
|
366
Visteon
VC
$3.41B
| $34.4M | 0.04% |
266,168
-52,303
| -16% | -$6.76M |
|
367
CVS Health
CVS
$93.6B
| $34.2M | 0.04% |
532,004
-405,452
| -43% | -$26.1M |
|
368
Cisco
CSCO
$264B
| $34.2M | 0.04% |
794,291
-1,370,432
| -63% | -$59M |
|
|
MYOK
369
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $34.1M | 0.04% |
687,538
+305,841
| +80% | +$15.2M |
|
370
Portland General Electric
POR
$4.69B
| $34M | 0.04% |
795,539
+189,795
| +31% | +$8.12M |
|
371
Five Below
FIVE
$8.46B
| $34M | 0.04% |
347,607
+332,693
| +2,231% | +$32.5M |
|
372
Quanta Services
PWR
$55.5B
| $33.9M | 0.04% |
1,015,879
+145,230
| +17% | +$4.85M |
|
373
Kinder Morgan
KMI
$59.1B
| $33.5M | 0.04% |
1,895,638
-2,210,389
| -54% | -$39.1M |
|
|
XL
374
DELISTED
XL Group Ltd.
XL
| $33.3M | 0.04% |
+595,046
| New | +$33.3M |
|
375
Adtalem Global Education
ATGE
$4.83B
| $33.1M | 0.04% |
687,720
-17,881
| -3% | -$860K |
|